Dr. Miver Erem Tokuş
NeurosurgeryVerified
- 24+years exp.
English · Turkish
60 seconds · no obligationView Profile
Surgical treatment of epilepsy offers selected patients with drug-resistant focal seizures a chance at seizure freedom or substantial seizure reduction. This clinical guide covers pre-surgical evaluation protocols, resective surgery, laser interstitial thermal therapy, neuromodulation devices, approximate costs in Turkey compared with the UK, US and Germany, post-operative recovery milestones, potential neurological risks and practical questions to ask your multidisciplinary surgical team.
A written plan with the surgeon's name and the full price — usually within 24 hours.

1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
NeurosurgeryVerified
English · Turkish
60 seconds · no obligationView Profile
The surgical treatment of epilepsy encompasses a specialised spectrum of neurosurgical procedures designed to stop or significantly decrease seizures in patients whose condition does not respond adequately to medical therapy. Epilepsy involves recurrent seizures caused by abnormal, hypersynchronous electrical discharges from clusters of cerebral neurons. In roughly thirty percent of individuals, anti-seizure medications fail to provide satisfactory seizure control. When seizures consistently originate from a distinct, identifiable region of brain tissue—the epileptogenic zone—surgically resecting, disconnecting, or ablating that focal area can disrupt the abnormal network and achieve long-term seizure freedom or substantial symptom relief.
Epilepsy surgery includes open resective craniotomies, minimally invasive stereotactic laser ablation, and implanted neuromodulation systems. Patients exploring surgical treatment of epilepsy Turkey will find specialised centres equipped for comprehensive diagnostic and operative care. Comprehensive centres providing surgical treatment of epilepsy in Turkey offer these interventions following multi-stage diagnostic evaluations. This guide reviews evaluation steps, clinical evidence, recovery milestones, procedural risks, and approximate costs compared with the UK, US, and Germany. For broader neurosurgical care, see our guide to neurosurgery treatments in Turkey.
Before any surgical procedure is planned, candidates undergo an exhaustive diagnostic sequence to locate the epileptogenic zone and confirm that intervention will not cause unacceptable neurological deficits. A formal surgical treatment of epilepsy evaluation establishes whether a patient has a single resectable focus through two progressive phases.
Patients stay in an inpatient Epilepsy Monitoring Unit (EMU) for continuous video-electroencephalography (video-EEG) over several days to capture and analyse habitual seizures. High-resolution 3-Tesla epilepsy-protocol MRI identifies structural lesions such as hippocampal sclerosis, focal cortical dysplasia, or cavernous malformations. Positron Emission Tomography (PET) maps interictal glucose hypometabolism, while ictal SPECT scans assess cerebral blood flow during seizure onset. Detailed neuropsychological testing evaluates baseline memory, language, and executive functions.
When Phase 1 results are inconclusive or the seizure focus borders critical speech or motor cortex, Phase 2 monitoring is performed. Neurosurgeons place stereotactic depth electrodes directly into targeted cerebral structures (stereo-EEG) or place subdural grids directly across the cortical surface. These electrodes record electrical activity over one to two weeks, precisely mapping seizure onset pathways and identifying vital functional boundaries through extra-operative electrical stimulation mapping.
Robust clinical evidence shows that surgical treatment of epilepsy is significantly more effective than continued medication for drug-resistant focal epilepsy. Randomised controlled trials, including landmark research by Wiebe and colleagues in the New England Journal of Medicine, demonstrate that 58 to 68 percent of patients with temporal lobe epilepsy achieve complete seizure freedom at one year post-surgery, compared with only 8 percent maintained on medication alone. Quality of life and psychosocial functioning also show marked gains.
Long-term studies indicate that roughly half of temporal lobectomy patients remain completely seizure-free after ten years, with many others experiencing substantial reductions in seizure frequency and severity. Extratemporal resections yield seizure-freedom rates between 40 and 60 percent, as defining clear surgical margins in frontal or parietal cortex is technically more challenging. For patients whose seizure focus overlaps eloquent areas, neuromodulation therapies such as Vagus Nerve Stimulation (VNS) or Deep Brain Stimulation (DBS) provide meaningful palliative relief, reducing seizure frequency by 50 percent or more in approximately half of recipients.
The cost of epilepsy surgery depends on the required pre-surgical evaluation, whether invasive stereo-EEG monitoring is needed, and the specific surgical technique or hardware chosen. The table below outlines approximate, broad price ranges across key destinations. These figures represent general estimates rather than hospital-specific quotes.
| Country | Approximate cost range |
|---|---|
| Turkey | €12,000 – €28,000 |
| United Kingdom | €25,000 – €65,000 |
| United States | €45,000 – €140,000 |
| Germany | €22,000 – €55,000 |
Several factors affect the surgical treatment of epilepsy cost. Standard focal resections with Phase 1 testing sit at the lower end of the range. Complex cases requiring invasive stereo-EEG, extended neuro-intensive care, or implanted neurostimulators fall toward the higher tier. When comparing international centres, the overall surgical treatment of epilepsy price reflects both diagnostics and operative care. Treatment packages in Turkey typically include pre-operative neuroimaging, surgical fees, anaesthesia, intensive care, hospital stay for the patient and a companion, medications, and airport transfers.
Epilepsy neurosurgery includes distinct modalities tailored to the seizure source. Patients considering specialised neurosurgical care typically evaluate three main approaches.
| Technique | Best suited to | Typical limits |
|---|---|---|
| Resective surgery (temporal lobectomy or lesionectomy) | Well-defined focal seizure source in non-eloquent cortex; hippocampal sclerosis | Requires craniotomy; potential visual field or verbal memory changes |
| Laser interstitial thermal therapy (LITT) | Deep or surgically difficult focal lesions; hypothalamic hamartomas | Minimally invasive; less suitable for extensive or ill-defined seizure networks |
| Neuromodulation (VNS, RNS, or DBS) | Multifocal seizure sources, foci in eloquent cortex, or failed prior resections | Palliative; rarely achieves total seizure freedom; requires eventual battery replacement |
Disconnection procedures, such as corpus callosotomy and hemispherotomy, are also used in specific cases—particularly in paediatric patients with severe drop attacks—to stop seizure spread across hemispheres without removing large volumes of brain tissue.
Surgical candidacy is considered when a patient meets the International League Against Epilepsy criteria for drug-resistant epilepsy: failure of adequate trials of two tolerated and appropriately chosen antiseizure medications to achieve sustained seizure freedom. Trying a third medication offers less than a five percent probability of seizure freedom, making timely surgical evaluation essential to prevent ongoing neurological and social disability.
Suitable candidates typically have focal seizures originating from an identifiable brain region that can be safely removed without causing major neurological deficits. Candidates must be medically stable for general anaesthesia and craniotomy, with adequate cognitive and psychological support for recovery. Patients with idiopathic generalised epilepsy or severe progressive neurodegenerative disorders are generally not candidates for resective surgery, though neuromodulation may provide palliative seizure reduction.
The surgical approach depends on whether open resection, laser ablation, or device implantation is planned. For open resections, the procedure begins with general anaesthesia. The patient's head is stabilised in a cranial fixation frame, and advanced neuronavigation systems link surgical instruments to 3D MRI scans in real time.
When the seizure focus borders speech or motor areas, an awake craniotomy with cortical stimulation mapping may be performed so the patient can speak or move during mapping to safeguard functional zones. The surgeon performs a tailored craniotomy, opens the dura, and places electrocorticography (ECoG) strips directly on the cortex to record abnormal spikes. The epileptogenic tissue is excised using microsurgical instruments and ultrasonic aspiration, preserving critical blood vessels. Post-resection ECoG confirms reduction of epileptiform activity. The dura is closed water-tight, the bone flap is secured with titanium plates, and the scalp is closed. The procedure typically lasts three to six hours.
Following surgery, surgical treatment of epilepsy recovery requires structured medical observation. Patients spend 24 to 48 hours in a neuro-intensive care unit (NICU) where neurological status, pupil reflexes, and vital signs are monitored. Patients then transfer to a standard ward for mobilization and wound care.
For international patients travelling to Turkey, a total stay of 12 to 16 days is customary. This allows for pre-operative imaging, surgery, hospital recovery, post-operative neuroimaging, suture removal around day 10 to 12, and final clearance from the neurosurgeon. Most patients resume light activities within two to four weeks and return to non-strenuous work within six to eight weeks. Vigorous exercise and contact sports must be avoided for at least three months. Anti-seizure medications must continue unchanged for one to two years, with adjustments managed gradually by an epileptologist based on follow-up EEG findings.
Epilepsy neurosurgery carries general surgical risks alongside procedure-specific neurological considerations. Reports from the NHS, NICE, and international neurosurgical societies identify general risks such as post-operative bleeding, wound infection, cerebrospinal fluid leaks, meningitis, deep vein thrombosis, and anaesthesia reactions. Major mortality rates in accredited neurosurgical centres remain under one percent.
Understanding surgical treatment of epilepsy risks allows individuals to balance procedural safety against ongoing seizure hazards. Site-specific neurological risks depend on the resection location. Dominant anterior temporal lobectomy carries a risk of mild verbal memory decline or word-finding difficulty. Injury to Meyer's loop can cause an upper quadrant visual field cut (superior quadrantanopia), which is usually asymptomatic but can affect driving regulations. Resections near motor pathways carry a small risk of weakness. Pre-operative neuropsychological evaluations help patients and families understand these risks and balance them against the persistent hazards of uncontrolled seizures.
Selecting a hospital requires verifying its multidisciplinary infrastructure. An advanced facility should meet comprehensive epilepsy centre standards, featuring fellowship-trained epilepsy neurosurgeons, adult and paediatric epileptologists, neuroradiologists, and clinical neuropsychologists who review cases collaboratively in formal multidisciplinary team (MDT) meetings.
Key requirements include an inpatient video-EEG unit, 3-Tesla epilepsy-protocol MRI, intraoperative neuro-monitoring, and a dedicated neuro-intensive care unit. Red flags include clinics proposing surgery without inpatient video-EEG Phase 1 evaluation, solo surgeons operating without epileptologist review, guarantees of complete cure, and pricing packages that omit intensive care or follow-up imaging. To understand our patient coordination, review how it works or visit our free quote page.
Before agreeing to surgery, discuss these essential questions during your neurosurgical consultation to clarify personal expectations and risks:
To assess your suitability for surgery, consult our medical travel pathway or request a free evaluation from an accredited epilepsy neurosurgery centre.
Surgical treatment of epilepsy involves neurosurgical procedures designed to stop or reduce unmanageable seizures in drug-resistant patients. By identifying the exact brain region where seizures originate—the epileptogenic zone—surgeons can resect abnormal tissue, ablate it using stereotactic lasers, or implant neuromodulation devices that interrupt abnormal electrical networks.
Yes, for properly selected candidates with drug-resistant focal epilepsy, surgery is highly effective. Randomised clinical trials show that 58 to 68 percent of patients with temporal lobe epilepsy achieve complete seizure freedom after resective surgery, compared with under 10 percent on continued medication. Extratemporal resections and neuromodulation yield slightly lower but meaningful reductions.
Approximate costs in Turkey range from €12,000 to €28,000, compared with €25,000 to €65,000 in the UK and up to €140,000 in the US. The price depends on whether Phase 2 invasive stereo-EEG monitoring is needed, the surgical technique used, and the length of intensive care monitoring required.
Before surgery, patients experience disruptive seizures, driving bans, and heavy medication side effects. After successful surgery, many achieve total seizure freedom or a marked reduction in seizure frequency, enabling them to gradually regain personal independence, return to work, and in some cases reduce medication under careful clinical supervision.
Immediate hospitalisation lasts five to seven days, including one to two nights in intensive care. Most patients recover basic energy and return to light desk activities within six to eight weeks. Full tissue healing takes several months, and anti-seizure medications must be continued for at least one to two years.
The brain tissue itself does not feel pain. Surgery is performed under general anaesthesia or local scalp block. Post-operatively, patients experience headache, scalp soreness, and jaw stiffness from muscle incisions, which are effectively controlled with prescribed analgesics and typically settle over the first one to two weeks.
For many patients, seizure freedom achieved through resective surgery is long-lasting. Long-term studies show that roughly 50 percent of patients remain completely seizure-free ten or more years after surgery. Even if minor auras or occasional late seizures recur, seizure frequency and severity usually remain significantly improved compared to pre-surgical levels.
Modern epilepsy surgery carried out in accredited neurosurgical centres is generally safe, with major perioperative mortality below one percent. However, neurosurgery carries potential risks including infection, haemorrhage, and site-specific neurological changes such as partial visual field deficits or verbal memory decline, which are thoroughly evaluated before surgery.
Resective surgery aims to permanently remove the epileptogenic zone and offers the highest chance of complete seizure cure. Neuromodulation (such as VNS or DBS) does not remove brain tissue; instead, it delivers electrical pulses to disrupt seizure pathways, serving as a palliative option that reduces seizure frequency by roughly half.
Patients typically need 12 to 16 days in Turkey. This window accommodates pre-operative neuroimaging, hospital admission, surgery, an intensive care stay, post-operative monitoring, wound inspection, and suture removal around day 10 to 12. If invasive stereo-EEG monitoring is required before resection, the stay may extend to three or four weeks.
Your request is in!
Your coordinator will contact you — usually within 2 hours, 24/7.
Want a faster, more accurate assessment?
Add photos & medical detailsLeave your number — a coordinator calls you in your language, usually within 15 minutes during office hours.
Thank you!
A coordinator will contact you at the time you chose.